CORDIS · 908507 · FP7
nano-PhotoMed Targeted Nano-Photomedicines for Multi-spectral Photodynamic Therapy of Cancer
Coordinator: AMRITA VISHWA VIDYAPEETHAM (IN)
We propose to develop multifunctional, targeted nano-photomedicines that are capable of bypassing biological barriers to deliver nano-engineered photosensitizer drugs and molecular-imaging agents to tumor tissues and angiogenetic micro-vasculature. Specifically, a unique nanomedicine system for targeted multi-spectral photodynamic therapy is proposed. The system consists of (i) luminescent quantumdot (QD) conjugated with photosensitizer (PS) drugs, which can be sensitized at its maximum efficiency using radiations of deep-tissue penetration (ii) molecular-imaging agents for the early stage de…
About Seventh Framework Programme (2007–2013)
The Seventh Framework Programme (FP7) ran from 2007 to 2013 and was the EU's main research-funding instrument of that period. It mobilised roughly €50 billion across cooperation projects, ERC frontier grants, Marie Curie fellowships, capacity-building actions and Euratom research. FP7 closed to new calls in 2013 but its projects continued for years after under their original grant agreements.
EU contribution: €15k awarded to the consortium. The project runs over approximately 1 year from 2009-10-01 to 2010-09-30.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu →More from IN
see all →- IMPACT — Improved Millets for Phosphate ACquisition and Transport921672 · FP7 · €15k
- Aquatic N in India — Fate of anthropogenic nitrogen in aquatic systems of India908496 · FP7 · €15k
- PEDPCREACT — Pedestrian pre-crash reactions and their effects on crash outcomes909605 · FP7 · €15k
- 2D-HETEROSTRUCTURES — Graphene Heterostructures by Self-Assembly:Top-down meets Bottom-up913877 · FP7 · €15k
- Latex film formation — Investigations on the effect of reactive surfactants on latex film microstructure and properties via tracer diffusion908349 · FP7 · €15k
- MITOTRAFFICBYMIRO — Differential role of atypical Rho GTPases Miro-1 and Miro-2 for controlling mitochondrial dynamics and transport913033 · FP7 · €15k
Other FP7 projects
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FR · €250.0M
- COMBACTE-NET — Combatting Bacterial Resistance in Europe115523 · SE · €109.4M
- EUC²LID — European Lead Factory115489 · DE · €80.0M
- COMBACTE-MAGNET — Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections115737 · SE · €75.3M
- ENABLE — European Gram Negative Antibacterial Engine115583 · UK · €58.9M
- PLACES2BE — Pilot Lines for Advanced CMOS EmbodimentS in 2x nodes, Built in Europe325633 · FR · €52.6M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Seventh Framework Programme (2007–2013) programme, under the MC-IIFR funding scheme.
- What is the EU contribution?
- The European Commission contributes €15k toward a total project budget of €15k.
- Which EU programme funds it?
- The project is funded under Seventh Framework Programme (2007–2013).
- Who coordinates the project?
- The project is coordinated by AMRITA VISHWA VIDYAPEETHAM (IN).
- What is the project timeline?
- The project runs from 2009-10-01 to 2010-09-30 — approximately 1 year.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 908507.